In January–August of this year, the output of basic pharmaceutical products and pharmaceutical preparations in Kazakhstan reached 121.3 billion tenge, 5.7% higher in value terms than a year earlier. Production of pharmaceutical preparations and medical materials grew by 6% to 116.9 billion tenge, while the output of basic pharmaceutical products declined slightly, down 0.1% to 4.4 billion tenge.
Regionally, Shymkent accounted for the largest share of production, at 45.6 billion tenge, marking year-on-year growth of 10.6%. Almaty Region (28.8 billion tenge, up 4.2%) and Karaganda Region (22.7 billion tenge, up 1.2%) also ranked among the top three. Rounding out the top five producers were Almaty (16.1 billion tenge, up 1.3%) and Aktobe Region (2.8 billion tenge, up 24.6%).
Turning to imports: in January–July of this year, Kazakhstan imported 17.8 thousand tons of medicines worth 1.2 billion US dollars—significantly less than in the same period of 2024. The decline amounted to 18.6% in volume terms and 4.7% in value terms.
From CIS countries, 5.4 thousand tons of medicines worth 90.4 million US dollars were imported. Russia accounted for the largest share, at 4.2 thousand tons. Belarus (569 tons) and Ukraine* (539.2 tons) were also among the top three suppliers.
From outside the CIS, Kazakhstan imported 12.4 thousand tons of medicines worth 1.1 billion US dollars. China was the leading supplier with 3.5 thousand tons. India, Germany, France, and Turkey also ranked among the top five exporters.
* Ukraine’s status within the CIS is disputed for a number of reasons.
